September 2003
ACP Journal Club;Sep/Oct2003, Vol. 139 Issue 2, p54
Academic Journal
Presents a list of articles about diseases that passed the criteria of "ACP Journal Club" for inclusion in the journal. "Suboptimal Monitoring and Dosing of Unfractionated Heparin in Comparative Studies With Low-Molecular-Weight Heparin"; "Evidence for Use of Coronary Stents: A Hierarchical Bayesian Meta-Analysis"; "Surgery for Parkinson's Disease: Lack of Reliable Clinical Trial Evidence."


Related Articles

  • Direct Percutaneous Carotid Access for Carotid Angioplasty and Stenting. Bergeron, Patrice // Journal of Endovascular Therapy (Sage Publications Inc.);Feb2015, Vol. 22 Issue 1, p135 

    Purpose: To describe a direct percutaneous carotid access technique for carotid artery stenting (CAS) that circumvents the potential for embolization that can occur during catheter manipulation in the aortic arch during femoral access. Technique: After inducing anesthesia, an ultrasound...

  • Non nonergot for Parkinson's disease shows good tolerance. Sterling, Lisa Pelton // Drug Topics;7/21/97, Vol. 141 Issue 14, p15 

    Reports that Mirapex has been approved by the Food & Drug Administration for the management of early and advanced stages of idiopathic Parkinson's disease (IPD). Information on Mirapex; Views of experts that levodopa therapy accelerates the progression of IPD; Comments from Peter LeWitt,...

  • Fetal brain transplantation: Questionable human experiment.  // America;11/28/1992, Vol. 167 Issue 17, p421 

    Argues that transplanting fetal brain tissue to the brains of patients with terminal neurological disease represents a double violation of medical morality. The transferring small grafts or cell suspensions of tissue by direct injection into the adult human brain; For patients suffering from...

  • Use of Tocopherol vs. Deprenyl in Early Parkinson's Disease.  // American Family Physician;7/1/1993, Vol. 48 Issue 1, p129 

    Summarizes the article `Use of Tocopherol vs. Deprenyl in Early Parkinson's Disease' from the `New England Journal of Medicine,' dated January 21, 1993. Effects of tocopherol and deprenyl in patients with Parkinson's Disease; Medication versus placebo; Recommendation.

  • Parkinson's disease: Managing symptoms and preserving function. Sweeney, Patrick J. // Geriatrics;Sep95, Vol. 50 Issue 9, p24 

    Discusses strategies of drug therapy for Parkinson's disease. Administration of neuroprotective therapy; Factors to consider in symptomatic therapy; Therapy based on levodopa (L-dopa); Manner of clearing of absorbed L-dopa from the plasma; Implications of long-term levodopa treatment;...

  • Pharmacologic options for managing Parkinson's disease. Evidente, Virgilio G.H.; Adler, Charles H. // Formulary;Jun97, Vol. 32 Issue 6, p594 

    Presents pharmacologic therapy for idiopathic Parkinson's disease (IPD). Most effective drugs for both early and advanced IPD; Useful drugs for patients with mild disease and minimal disability; Complication of levedopa; Clinical trials on drugs that delay progression of parkinson's disease. ...

  • When bran is bad. Gutfeld, Greg; Rao, Linda // Prevention;Sep92, Vol. 44 Issue 9, p26 

    Discusses how bran may hinder therapy for someone with Parkinson's disease by undermining man-made dopamine drugs used to fight the illness. Pyridoxine (vitamin B-6) found in bran is the culprit; Definition of Parkinson's disease; How the drug L-dopa controls the disease; Advice to those who...

  • Parkinsonism: Myths, dogma and the hope of prophylaxis. Dobbs, R. John; Dobbs, Sylvia M. // Age & Ageing;Nov92, Vol. 21 Issue 6, p389 

    Presents commentary on the progress in the management of idiopathic parkinsonism. Levodopa/decarboxylase inhibitor combinations; Work's reliance on gross clinical definition of the syndrome; Manifestations of idiopathic parkinsonism the same in young and old; Hope of prophylaxis; Longitudinal...

  • Can bran team up with Parkinson's drug?  // Prevention;Jun93, Vol. 45 Issue 6, p31 

    Discusses the research efforts of Spanish scientists who thought it was worth finding out if adding insoluble fiber to the diets of 19 Parkinson's patients improved either their constipation or the effectiveness of L-dopa treatment. Methods; Results; Discussion.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics